MHIF Treats First Patient in AccuCinch Study for Mitral Regurgitation and Heart Failure

Guided Delivery Systems Announces Senior Leaders and Company Name Change to Ancora Heart

Ancora Heart Enrolls First Patient in U.S. Early Feasibility Study of First-of-Its-Kind Investigational Heart Failure Therapy

Ancora Heart Enrolls First Patient in European Multi-Center Study of First-of-Its-Kind Investigational Heart Failure Therapy

The Christ Hospital Health Network First in Ohio to Use New Minimally Invasive Approach for Treating Heart Failure

First Belarusian patients implanted with an innovative device for the treatment of heart failure

Ancora Heart Announces Key Activities for Transcatheter Cardiovascular Therapeutics 2019

Ancora Heart Announces Positive Safety and Efficacy Data from Study of First-of-Its-Kind Investigational Heart Failure Therapy

Ancora Heart sees positive early results with Accucinch in systolic heart failure

Tales from TCT 2019: Ancora’s Heart Felt Data

To Learn More

GET IN TOUCH